Symposium Explores Clinical Trial Design and Multidrug Resistance in Blood Cancers
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
Tag: Blood Cancer Discovery
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
When teacher Ellen Reich began treatment for multiple myeloma in 2014, a sequence of therapies approved by the U.S....
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a...
Blood cancer patients are highly vulnerable to COVID-19 infection. Now mounting evidence suggests they may be also among the least protected...
The cover of the inaugural issue of Blood Cancer Discovery, launched in July 2020, does not feature stained tissue...
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells...
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
In 2012, Carl June, MD, a pioneer in the development of chimeric antigen receptor (CAR) T-cell therapy, helped treat Emily Whitehead, the...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....